(Q38639109)

5 September 2017

Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model (English)

1 reference

5 September 2017

1 reference

Jørgensen HS

1

1 reference

5 September 2017

Nakayama H

2

1 reference

5 September 2017

Kammersgaard LP

3

1 reference

5 September 2017

Raaschou HO

4

1 reference

5 September 2017

Olsen TS

5

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

5 September 2017

1 reference

5 September 2017

319

1 reference

5 September 2017

7205

1 reference

5 September 2017

288-289

1 reference

Tissue plasminogen activator for acute ischemic stroke

5 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28179

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

6 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28179

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

23 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28179

Effect of blood pressure and diabetes on stroke in progression

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10426737

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.319.7205.288

1 reference

5 September 2017

1 reference

5 September 2017

PubMed publication ID

10426737

1 reference